Propofol or methohexitone was given to the same twenty patients on two separate occasions during total intravenous anaesthesia for microlaryngeal surgery. With propofol the quality of induction was superior. Fewer patients required supplementation. Heart rate and blood pressure were well controlled at levels of 110-120% baseline. There were fewer side-effects during maintenance and recovery. Patients were able to return home earlier. However, apnoea and pain on injection occurred frequently, the latter when injection was made into the dorsum of the hand. With methohexitone, apnoea, abnormal movement, nausea, vomiting, headache, restlessness and confusion were common. Cardiovascular variables were poorly maintained at levels of 170-180% baseline. The results suggest that propofol is suitable as the sole anaesthetic agent in patients undergoing microlaryngeal surgery.
This study sought to establish whether propofol was preferable to methohexitone for this application. Attention was focused on cardiovascular stability, the incidence of respiratory and other miscellaneous side-effects, the need for anaesthetic supplementation and the speed and quality of recovery. The hypothesis tested was that propofol was superior to methohexitone for each of these outcomes.
MATERIAL AND METHODS

Patient selection
A randomised, single-blind, crossover trial was performed on twenty patients who underwent total intravenous anaesthesia for elective recurrent microlaryngeal surgery. The trial design provided a unique opportunity to study the effects of repeat anaesthetics in the same patients. Each patient received both treatments. Approval for this study was obtained from the Hospital Medical Ethics Review Committee. Informed consent was given by each patient studied.
Patients were excluded from participation if they had known allergies to any of the trial medications or their constituents, were pregnant, had significant upper airways disease, required tracheotomy or had previous episodes of adverse reactions to anaesthesia. No selection on the basis of sex was made. All patients were studied on two separate occasions. At their first visit patients were randomly allocated to receive either methohexitone or propofol anaesthesia. They received the other treatment on their next visit.
Premedication, induction and maintenance
Patients received a variety of premedicants according to previous experience and their known preferences. Nevertheless, each patient received the same premedicant on each visit. Fifteen patients received papaveretum (0.3 mg/kg)/ hyoscine (6 mcg/kg) given intramuscularly 60 minutes prior to induction of anaesthesia. Three patients received both pethidine (1.5 mg/kg) and promethazine (25 mg), one patient received oral temazepam (20 mg) and the remaining patient received intravenous fentanyl (1.5 mcg/kg) in the anaesthetic bay ten minutes prior to the procedure.
Induction was achieved with either methohexitone (1.5 mg/kg) or propofol (2 mg/kg) given intravenously over approximately 30 seconds into a peripheral vein. With both treatments paralysis was secured using intravenous suxamethonium (100 mg) and the larynx sprayed with 10% lignocaine hydrochloride aerosol immediately prior to intubation with a Benjet l7 tube. The lungs were intermittently insufflated with oxygen alone via a jet insufflator.
Anaesthesia was maintained by an intravenous infusion of either methohexitone (6 mg/kg/hr) or propofol (10 mg/kg/hr) and commenced immediately following induction. Continued muscle relaxation was achieved via an infusion of suxamethonium (8 mg/kg/hr) and additional boluses given as required. When necessary, a bolus of either propofol (20-30 mg) or methohexitone (20-30 mg) , was administered in order to maintain adequate clinical anaesthesia and to keep haemodynamic parameters to within 30% of baseline measurements. Supplementation of either anaesthetic treatment or muscle relaxant was noted.
Assessments and statistical analysis
In all patients, heart rate (HR), systolic, diastolic and mean arterial blood pressure (MAP) was recorded using a noninvasive oscillometric arterial pressure sensing device (Dinamap 1846, Critikon). The cuff was positioned around the brachial artery of the patient on the contralateral arm to that of the infusion. From the results obtained the heart ratesystolic arterial pressure product (rate pressure product, RPP) was calculated. All haemodynamic parameters were noted before induction and at 1,2, 3, 5, 10, 15, 20, 25, 30 and 35 minutes following induction and also during the first three minutes of recovery.
Before induction of anaesthesia at least three baseline readings were taken approximately three to five minutes apart for each haemodynamic variable. The mean of these readings was taken to represent before induction control.
Side-effects including abnormal movement, excitatory phenomenon, pain on injection, headache, nausea, restlessness and confusion were recorded during induction, maintenance and recovery from anaesthesia. These were noted as being present or absent. The severity of side-effects was not assessed, nor was the duration of apnoea after suxamethonium was given. The quality or smoothness of induction was assessed subjectively by one of the trial investigators (NB). Smoothness was graded good, adequate or poor. It was deemed good if no abnormal muscular movements occurred and no supplementation was required during induction, adequate if some movement occurred and poor if excessive movement was observed. The onset of anaesthesia was defined as the interval between start of induction and the time until the patients dropped a water-filled syringe.
Recovery from anaesthesia occurred spontaneously and was assessed by the patient's ability to open his or her eyes on command, to recall date of birth and to sit upright. On return to the ward each patient was asked whether he/she experienced nausea, vomiting, headache, restlessness, confusion and tremor at any stage during or after the procedure. The time that each patient was capable of returning home was noted. Normal recovery room practice was not modified by the study.
Statistical analysis of the results was carried out using the MINITAB (Minitab Inc., University of Pennsylvania) and BMDP (BMDP Inc., University of California) software packages. Comparisons of incidence of side-effects were performed by either the Chi-Square test, Kappa coefficient of concordance or the Fisher's exact test. Haemodynamic, demographic and time interval data were compared using the Student's t-test for paired and unpaired observations. A probability value of P < 0.05 was considered to be statistically significant.
RESULTS
A total of twenty patients of ASA class 1 to 3, aged 21 to 63 years and weighing 51 to 86 kg were studied. Together these patients had previously been admitted to our institution on 152 separate occasions within the last five years for correction of their current complaint. Mostly these patients were admitted with papilloma of the vocal cords. Treatment was usually microlaryngoscopy, biopsy and laser surgery. There were no sex-related differences between treatments. Nor were anaesthetic and procedure durations, onset of anaesthesia and dose of suxamethonium significantly different between treatments.
Procedures lasted approximately 21 ± 6.2 minutes in duration. The mean time between treatments was 82 days (range 28-154 days). Induction was achieved in all patients with the dose chosen. However, the quality and smoothness of induction differed between treatments (P < 0.05). Induction was considered good in all patients given propofol. By contrast, in patients given methohexitone, induction was good in thirteen, adequate in four and poor in three.
Pain on injection was more common with propofol than with methohexitone (Table 1) although there was no statistical difference between treatments. Pain with propofol however, only occurred when the dorsum of the hand was chosen as the site of injection. There was a significant difference between sites of injection (P< 0.01) and this difference was treatment dependent (P < 0.05).
Anaesthetic supplementation, either because of cardiovascular instability or inadequate depth of anaesthesia, was required more frequently after methohexitone ( Table 2) . Seventeen patients treated with methohexitone as opposed to ten patients treated with propofol required bolus supplementation (P < 0.05).
The incidence of side-effects following each treatment is shown in Table 3 . During induction, apnoea (P < 0.05) and pain on injection (P < 0.05) were more prevalent with propofol. Apnoea was observed in 50% of patients given propofol and 30% given methohexitone. Apnoea was absent in 45% of patients following induction with both treatments. Abnormal movement was more common with methohexitone (P < 0.05). So too were postoperative complications of nausea/ vomiting (P < 0.05), headache (P < 0.05), and confusion (P < 0.05). By comparison, recovery following propofol was mostly complication-free.
Recovery times in the early postoperative period were no different between treatments (Table 4 ). In both cases recovery from anaesthesia was rapid. Nevertheless, patients were able to return home earlier after propofol. The mean (± SO) time to return home was 3.5 ± 2.6 and 5.9 ± 3.6 hours after propofol and methohexitone respectively (P < 0.01). With propofol, fifteen patients were able to return home within four hours of anaesthesia while one remained overnight. Alternatively with methohexitone, only nine patients returned home within four hours while three stayed overnight. Those patients who remained overnight did so because of nausea or sedation.
Resting cardiovascular values were not different between treatments. At baseline mean HR was 75 ± 3.1 (± SO) and 73 ± 3.3 beats per minute before propofol and methohexitone treatment respectively. The corresponding SBP was 135 ± 3.2 and 137 ± 4.4 mmHg for these two treatments.
Following induction with methohexitone MAP and HR rose rapidly (P < 0.001) to 130-140% of baseline ( Figure 1 ). Rate pressure product continued to increase to a maximm of 180% of baseline.
The haemodynamic response to propofol was attenuated and significantly different from methohexitone (P < 0.05). Although propofol led to a slight elevation in both MAP and HR (to approximately 110% of baseline) this plateau was not different from baseline.
The contrasting cardiovascular instabilities of both methohexitone and propofol are further illustrated in the responses of one patient shown in Figure 2 . This patient required multiple supplements of methohexitone and despite this, MAP and HR remained poorly controlled at high levels. When the same patient was treated with propofol, haemodynamic parameters were little altered from baseline and no supplementation was required.
DISCUSSION
In the present study the suitability of total propofol anaesthesia for microlaryngeal surgery was examined by direct comparison with the established agent methohexitone. Each drug was given to all patients on separate occasions. The results suggest that propofol would be an ideal agent for this type of surgery. The data also indicate that propofol has distinct advantages over methohexitone.
In this study, propofol anaesthesia combined with high frequency jet ventilation generally Onset of action and recovery after infusion is rapid with both drugs. Nevertheless, induction with propofol was considered smoother. Quality of induction was good in all patients treated with propofol but in only 65% of patients after methohexitone. The latter treatment was associated with frequent abnormal movement on induction. These findings are similar to those reported by Mackenzie and Grant l8 although in their study the quality of induction after methohexitone was only good in 25% patients.
Consonant with the present findings, apnoea has been commonly reported after induction with propofol. In both premedicated and unpremedicated patients apnoea has been shown to occur in 35 to 50% patients I 9-20 and even at doses of 2 mg!k:g, a dose previously thought to avoid apnoea. 21 Although not measured in the present study apnoea commonly lasts more than thirty seconds l8 but its effect is dose-dependent. 22 Apnoea on induction with propofol is not generally considered to be of major concern 23 but may be reduced when induction doses are adminstered more slowly over 45 to 60 seconds as opposed to 15 to 30 seconds. 24 Pain on injection was also more common with propofol and was observed in 30% of patients. This study supports the view of others 25 that pain occurs more frequently when propofol is injected into small hand veins. Pain was absent when injected into the antecubital fossa. Thus pain should be reduced, if not eliminated, if large veins are used. Various other strategies· to minimise pain have been suggested. These have included the prior or concurrent administration of lignocaine hydrochloride 26 or the rapid use of opioid premedication. 27 Propofol has been shown previously to produce more cardiovascular depression than thiopentone, methohexitone or etomidate. 16 ,18,23,24 This study in part supports these findings but notes in contrast to Harries et aI., 28 that propofol provides greater cardiovascular stability than methohexitone. The hypotension that occurs immediately following induction with propofol is both slight and shortlived. During maintenance, heart rate and arterial pressure remain stable just above baseline. Methohexitone, however, causes a profound pressor response after induction which persists throughout maintenance. Heart rate and arterial pressure rise rapidly and remain elevated at 40-50% above baseline. Rate pressure product, considered to be an index of myocardial oxygen requirement, reaches levels of 80% above baseline. The arterial pressure response may have been attenuated if larger doses of methohexitone were used, but probably at the cost of prolonged recovery and more significant respiratory depression.
The question as to equipotency of the two treatment regimens is relevant to a meaningful comparison between the two drugs. In this study we cannot be certain that equipotency existed. However, for both propofoI 2 ,15,22 and methohexitone 23 ,24 induction and maintenance dosages regularly recommended in the literature were used.
Recovery was equally rapid with both treatments. Patients were able to sit upright within fifteen minutes after anaesthesia. These observations generally support those of others 23 ,24 but some suggest that recovery with propofol is faster. 14 Nevertheless, the quality of recovery is superior with propofol; patients exhibited fewer side-effects and were often alert and responsive. However, with methohexitone, patients frequently complained of headache, restlessness, confusion, nausea and vomiting.
Patients given propofol were able to return home earlier and fewer were required to remain in hospital overnight. Also when questioned about their anaesthetic preference, fourteen patients favoured propofol, five were undecided. One patient preferred methohexitone because the patient, when given propofol, remembered events in the recovery ward and found this disturbing. The net effect of these factors indicate that patients treated with propofol are likely to have a more pleasant hospital experience, are able to return to home and work earlier and require less postoperative care.
In conclusion, propofol used as a continuous infusion in combination with high-frequency jet ventilation proved acceptable for microlaryngeal surgery. Further, the data support the proposition that because of its superior cardiovascular stability Anaesthesia and Intensive Care. Vol. 19 . No. 1. February. 1991 and fewer side-effects, propofol IS preferable to methohexitone.
